-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $575

Benzinga·11/03/2026 16:02:14
Listen to the news
TD Cowen analyst Phil Nadeau maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $550 to $575.